Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Rationally Targeted, Conformationally Constrained, Oxetane‐Modified Oligonucleotides Demonstrate Efficient Gene‐Silencing Activity in a Cellular System

Identifieur interne : 002F64 ( Main/Exploration ); précédent : 002F63; suivant : 002F65

Rationally Targeted, Conformationally Constrained, Oxetane‐Modified Oligonucleotides Demonstrate Efficient Gene‐Silencing Activity in a Cellular System

Auteurs : J B Opalinska [Pologne] ; A M Gewirtz [États-Unis]

Source :

RBID : ISTEX:253B5542758C9179DA639680BFF5321715D693A7

English descriptors

Abstract

Antisense oligodeoxynucleotides (AS ODN) have been employed as gene‐silencing agents in the laboratory and, in the clinic. The in vivo use of these molecules has been facilitated by chemical modifications to the DNA backbone which augment their nuclease stability. Attempts to further improve the efficacy of AS ODN have largely focused on 2′ alterations of the ribose sugar that make the molecules more RNA like in structure. This increases the Tm of formed DNA/RNA hybrids but simultaneously prevents binding of RNaseH which is important for ODN effectiveness. Herein, we demonstrate the use of AS ODN containing nucleosides with a novel oxetane (OXE) modification [oxetane, 1‐(1′, 3′‐O‐anhydro‐β‐D‐psicofuranosyl nucleosides)] which augments Tm, enhances nuclease stability, and is permissive of RNaseH activation. We also illustrate herein the value of rational targeting of OXE modified, and by analogy, AS ODN of any chemical modification.

Url:
DOI: 10.1196/annals.1359.007


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Rationally Targeted, Conformationally Constrained, Oxetane‐Modified Oligonucleotides Demonstrate Efficient Gene‐Silencing Activity in a Cellular System</title>
<author>
<name sortKey="Opalinska, J B" sort="Opalinska, J B" uniqKey="Opalinska J" first="J B" last="Opalinska">J B Opalinska</name>
</author>
<author>
<name sortKey="Gewirtz, A M" sort="Gewirtz, A M" uniqKey="Gewirtz A" first="A M" last="Gewirtz">A M Gewirtz</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:253B5542758C9179DA639680BFF5321715D693A7</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1196/annals.1359.007</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-B40D3774-V/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F22</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F22</idno>
<idno type="wicri:Area/Istex/Curation">000F22</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A77</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A77</idno>
<idno type="wicri:doubleKey">0077-8923:2005:Opalinska J:rationally:targeted:conformationally</idno>
<idno type="wicri:Area/Main/Merge">002F95</idno>
<idno type="wicri:Area/Main/Curation">002F64</idno>
<idno type="wicri:Area/Main/Exploration">002F64</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Rationally Targeted, Conformationally Constrained, Oxetane‐Modified Oligonucleotides Demonstrate Efficient Gene‐Silencing Activity in a Cellular System</title>
<author>
<name sortKey="Opalinska, J B" sort="Opalinska, J B" uniqKey="Opalinska J" first="J B" last="Opalinska">J B Opalinska</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>aDepartment of Hematology, Pomeranian Medical University, Szczecin</wicri:regionArea>
<wicri:noRegion>Szczecin</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Pologne</country>
</affiliation>
</author>
<author>
<name sortKey="Gewirtz, A M" sort="Gewirtz, A M" uniqKey="Gewirtz A" first="A M" last="Gewirtz">A M Gewirtz</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>bDivison of Hematology/Oncology, Department of Medicine, and Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104</wicri:regionArea>
<wicri:noRegion>Pennsylvania 19104</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Annals of the New York Academy of Sciences</title>
<title level="j" type="alt">ANNALS OF NEW YORK ACADEMY SCIENCES</title>
<idno type="ISSN">0077-8923</idno>
<idno type="eISSN">1749-6632</idno>
<imprint>
<biblScope unit="vol">1058</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="39">39</biblScope>
<biblScope unit="page" to="51">51</biblScope>
<biblScope unit="page-count">13</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2005-11">2005-11</date>
</imprint>
<idno type="ISSN">0077-8923</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0077-8923</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Antisense</term>
<term>Antisense oligodeoxynucleotides</term>
<term>Antisense oligonucleotides</term>
<term>Biologic activity</term>
<term>Cell lysates</term>
<term>Cellular system</term>
<term>Control cells</term>
<term>Dppz moiety</term>
<term>Duplex</term>
<term>Gene expression</term>
<term>Gewirtz</term>
<term>Hamster fibroblast cells</term>
<term>Hybrid duplex</term>
<term>Hybridization</term>
<term>Identical sequence</term>
<term>Invitrogen corporation</term>
<term>Large decrease</term>
<term>Mapping procedure</term>
<term>Modification</term>
<term>Molecule</term>
<term>Mrna</term>
<term>Mrna levels</term>
<term>Mrna target</term>
<term>Nuclease stability</term>
<term>Nucleic</term>
<term>Nucleic acid</term>
<term>Nucleic acids</term>
<term>Nucleoporation</term>
<term>Nucleoside</term>
<term>Oligonucleotides</term>
<term>Opalinska</term>
<term>Opalinska gewirtz</term>
<term>Oxetane</term>
<term>Oxetane molecules</term>
<term>Phosphorothioate</term>
<term>Protein expression</term>
<term>Pvdf membrane</term>
<term>Real time detection</term>
<term>Rnase</term>
<term>Same extent</term>
<term>Slot blot</term>
<term>Sqrm</term>
<term>Sqrm molecules</term>
<term>Thermodynamic stability</term>
<term>Transfected cells</term>
<term>York academy</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Antisense oligodeoxynucleotides (AS ODN) have been employed as gene‐silencing agents in the laboratory and, in the clinic. The in vivo use of these molecules has been facilitated by chemical modifications to the DNA backbone which augment their nuclease stability. Attempts to further improve the efficacy of AS ODN have largely focused on 2′ alterations of the ribose sugar that make the molecules more RNA like in structure. This increases the Tm of formed DNA/RNA hybrids but simultaneously prevents binding of RNaseH which is important for ODN effectiveness. Herein, we demonstrate the use of AS ODN containing nucleosides with a novel oxetane (OXE) modification [oxetane, 1‐(1′, 3′‐O‐anhydro‐β‐D‐psicofuranosyl nucleosides)] which augments Tm, enhances nuclease stability, and is permissive of RNaseH activation. We also illustrate herein the value of rational targeting of OXE modified, and by analogy, AS ODN of any chemical modification.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Pologne</li>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="Pologne">
<noRegion>
<name sortKey="Opalinska, J B" sort="Opalinska, J B" uniqKey="Opalinska J" first="J B" last="Opalinska">J B Opalinska</name>
</noRegion>
<name sortKey="Opalinska, J B" sort="Opalinska, J B" uniqKey="Opalinska J" first="J B" last="Opalinska">J B Opalinska</name>
</country>
<country name="États-Unis">
<noRegion>
<name sortKey="Gewirtz, A M" sort="Gewirtz, A M" uniqKey="Gewirtz A" first="A M" last="Gewirtz">A M Gewirtz</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F64 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002F64 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:253B5542758C9179DA639680BFF5321715D693A7
   |texte=   Rationally Targeted, Conformationally Constrained, Oxetane‐Modified Oligonucleotides Demonstrate Efficient Gene‐Silencing Activity in a Cellular System
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021